These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 21799515)

  • 1. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.
    Rudolph U; Knoflach F
    Nat Rev Drug Discov; 2011 Jul; 10(9):685-97. PubMed ID: 21799515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.
    Rudolph U; Crestani F; Benke D; Brünig I; Benson JA; Fritschy JM; Martin JR; Bluethmann H; Möhler H
    Nature; 1999 Oct; 401(6755):796-800. PubMed ID: 10548105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective antagonism of GABAA receptor subtypes: an in vivo approach to exploring the therapeutic and side effects of benzodiazepine-type drugs.
    Rowlett JK; Cook JM; Duke AN; Platt DM
    CNS Spectr; 2005 Jan; 10(1):40-8. PubMed ID: 15618946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do subtype-selective gamma-aminobutyric acid A receptor modulators have a reduced propensity to induce physical dependence in mice?
    Mirza NR; Nielsen EØ
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1378-85. PubMed ID: 16352707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.
    Atack JR
    Curr Top Med Chem; 2011; 11(9):1203-14. PubMed ID: 21050171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha2-gamma-Aminobutyric acid (GABA)A receptors are the molecular substrates mediating precipitation of narcosis but not of sedation by the combined use of diazepam and alcohol in vivo.
    Täuber M; Calame-Droz E; Prut L; Rudolph U; Crestani F
    Eur J Neurosci; 2003 Nov; 18(9):2599-604. PubMed ID: 14622161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GABAA-BZR complex as target for the development of anxiolytic drugs.
    Trincavelli ML; Da Pozzo E; Daniele S; Martini C
    Curr Top Med Chem; 2012; 12(4):254-69. PubMed ID: 22204488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABAA receptor alpha2/alpha3 subtype-selective modulators as potential nonsedating anxiolytics.
    Atack JR
    Curr Top Behav Neurosci; 2010; 2():331-60. PubMed ID: 21309116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site.
    Atack JR
    Curr Drug Targets CNS Neurol Disord; 2003 Aug; 2(4):213-32. PubMed ID: 12871032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of genetic and pharmacological approaches to understanding the complexities of GABA(A) receptor subtype functions: the anxiolytic effects of benzodiazepines.
    Reynolds DS
    Pharmacol Biochem Behav; 2008 Jul; 90(1):37-42. PubMed ID: 18457867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation.
    Fischer BD; Teixeira LP; van Linn ML; Namjoshi OA; Cook JM; Rowlett JK
    Psychopharmacology (Berl); 2013 May; 227(2):347-54. PubMed ID: 23354533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype.
    Ralvenius WT; Benke D; Acuña MA; Rudolph U; Zeilhofer HU
    Nat Commun; 2015 Apr; 6():6803. PubMed ID: 25865415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating insomnia: Current and investigational pharmacological approaches.
    Ebert B; Wafford KA; Deacon S
    Pharmacol Ther; 2006 Dec; 112(3):612-29. PubMed ID: 16876255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the mechanism of action of hypnotics.
    Doble A
    J Psychopharmacol; 1999; 13(4 Suppl 1):S11-20. PubMed ID: 10667451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voltage-clamp evidence of GABA
    Fernandes H; Batalha V; Braksator E; Hebeisen S; Bonifácio MJ; Vieira-Coelho MA; Soares-da-Silva P
    Pharmacol Rep; 2022 Oct; 74(5):956-968. PubMed ID: 36097257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.
    Atack JR
    Curr Top Med Chem; 2011; 11(9):1176-202. PubMed ID: 21050172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive Effects of a Novel α2/α3-Subtype Selective GABA
    Lewter LA; Fisher JL; Siemian JN; Methuku KR; Poe MM; Cook JM; Li JX
    ACS Chem Neurosci; 2017 Jun; 8(6):1305-1312. PubMed ID: 28150939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA-based therapeutic approaches: GABAA receptor subtype functions.
    Rudolph U; Möhler H
    Curr Opin Pharmacol; 2006 Feb; 6(1):18-23. PubMed ID: 16376150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of GABAA receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders.
    Ator NA
    CNS Spectr; 2005 Jan; 10(1):31-9. PubMed ID: 15618945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.
    Ballard TM; Knoflach F; Prinssen E; Borroni E; Vivian JA; Basile J; Gasser R; Moreau JL; Wettstein JG; Buettelmann B; Knust H; Thomas AW; Trube G; Hernandez MC
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):207-23. PubMed ID: 18936916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.